Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
about
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after NeurosurgeryPenetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.The antibiotic and anti-inflammatory treatment of bacterial meningitis in adults: do we have to change our strategies in an era of increasing antibiotic resistance?What do we really know about antibiotic pharmacodynamics?Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant.Burden of bacterial meningitis: a retrospective review on laboratory parameters and factors associated with death in meningitis, kelantan malaysia.Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MICPharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.Bacterial meningitis: a review of effective pharmacotherapy.CNS pharmacokinetics of antifungal agents.Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis.Management of meningitis due to antibiotic-resistant Acinetobacter species.Penetration of colistin into cerebrospinal fluidTreatment strategies for central nervous system infections.Acute bacterial meningitis in infants and children: epidemiology and management.Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults.Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?Reply to Marx et al.Management of aminoglycosides in the intensive care unit.Survey of prophylactic antibiotic use amongst UK cochlear implant surgeons.Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem.
P2860
Q28080607-CF40580B-1143-4AF0-AF82-DE6AF4E96E72Q30370090-61197CA1-DBA2-40D8-99EB-E5F54D353F67Q34142328-A9524AA7-124C-476D-98F6-B9F55F26A853Q34402548-5B2DCB1A-5FF1-4B13-92BC-A2CB8E3D58F9Q34443407-6C7581E2-9FEA-47A9-A1FC-03851CF12C03Q34788854-22574802-3958-460D-A668-91C27E7F6DFFQ35181943-4C936249-5E3E-402D-A624-528CD6E11692Q35637864-C248DEB1-DA8B-4741-8ADC-52B5567BD032Q36083619-632D1879-EB9F-45BB-A8C9-D74F4EC09FD8Q36240752-37D61E16-A4F1-45F4-82C6-B0F57E3C55F4Q36895844-A8A3EE96-F71E-4052-9FA1-B52D113F06F4Q36909333-B7DC45C5-4D5C-4AEB-97FC-33956843CDF6Q37026552-8E50DC5B-DFF8-4588-8882-7DA5A16AC917Q37077629-75567005-E5FE-4FDD-8755-F98B88E8513AQ37144837-AB3917F1-2F3B-4407-97A0-CD491B473AFCQ37382976-BA65F15C-0E0B-46E5-935E-C590AB557FEFQ37409872-7CA542B7-BAA7-49EC-94C8-B2F6B4FAC20EQ37483938-894B384E-5437-4FFA-B066-27CC4672672FQ37945754-E719C50C-A787-4A22-B9D5-9053CBA213BDQ38054627-813BC0B9-020C-4287-BFBF-773D66A36DCEQ38093135-78D8728A-7BEB-4F4F-BAD3-6571EF28D845Q40047150-9BE1E551-70C8-4AE9-8233-50D7B4CF2D3BQ42019012-6F3D0350-820B-4BE7-8048-D02491A7D98AQ42908869-9D9D57E6-0680-49FD-84FD-8338556C91E0Q43663730-6FFD370E-4769-4625-84E2-9138AD1DA65AQ44564506-0A19AD54-85F5-4E31-95CE-9FC781A1A027Q44736207-1A235E5D-2253-47B2-A59B-7C8967465416Q51754688-D55CC8CB-B9E2-4FCA-B874-006DC23A098D
P2860
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
@ast
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
@en
type
label
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
@ast
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
@en
prefLabel
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
@ast
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
@en
P1476
Pharmacokinetics and pharmacodynamics of antibiotics in meningitis
@en
P2093
P304
P356
10.1016/S0891-5520(05)70096-9
P50
P577
1999-09-01T00:00:00Z